SOLMETEX, LLC is pleased to offer the Montgomery Bucks Dental Society's members an exclusive special offer on the Solmetex NXT Hg5™ series of amalgam separators, accompanied by the Solmetex Practice Waste Solutions (PWS) line of products. The PWS recycling solutions include amalgam buckets, lead & lead apron containers, sharps/biohazard disposal and photo-chemical recovery. The Solmetex product line provides the "Total Solution" for waste handling and recycling, along with Certificates of Compliance available online 24/7 at www.solmetex.com.

"Solmetex is honored to have been selected by the Montgomery Bucks Dental Society as their exclusive partner. Our company is committed to ensuring compliance to the members of the MBDS by providing the best products and services available. The award winning Hg5 series of amalgam separators and the Practice Waste Solutions (PWS) line of products offer a simple and total solution for all waste handling and recycling needs for the dental practice."

~ Michael Toole, Vice President of Sales & Marketing

For a limited time, Montgomery Bucks members can take advantage of the "Solmetex Product Bundle" which includes an NXT Hg5 Amalgam Separator and a Practice Waste Solutions Amalgam Bucket for just $298. This bundle is $677 off the suggested retail price of $975. This offer is good through May 31, 2018. After this time period, Solmetex is then offering Montgomery Bucks members, who purchase a new Solmetex NXT Hg5 Series Amalgam Separator, one 2.5 gallon PWS Amalgam Bucket with Recycling Kit free, a retail value of $168.

“The members of the Montgomery Bucks Dental Society are on the forefront of patient care and community service. As such, we are always searching for products and services to support our goals and keep the costs of healthcare delivery at reasonable levels. We are proud to partner with Solmetex, a leader in waste amalgam separation and recovery, to offer our membership an exclusive cost savings opportunity. It is an honor for us to be working with them.

~ David M. Kaffey, DDS, President – elect, Montgomery Bucks Dental Society

For questions regarding the regulation and/or this press release, please visit: www.solmetex.com/regulation, or contact Solmetex #508-393-5515.

Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care products and services to office-based dental, animal health, and medical practitioners, and Internet Brands, a leading provider of web presence and online marketing software, announced today the creation of a joint venture designed to deliver integrated dental technology to help the profession improve practice management and marketing as well as patient communication.

Henry Schein Practice Solutions is the leading dental practice management software company and will bring to the venture its market-leading suite of practice management systems. Internet Brands is the market leader in web-based software applications used by dental offices to attract and retain patients and manage online reputation.

The joint venture, to be named Henry Schein One, will include the Henry Schein Practice Solutions products and services, such as Dentrix, Dentrix Ascend, Easy Dental, and TechCentral, as well as Henry Schein's international dental practice management systems, including Software of Excellence, Logiciel Julie, InfoMed, Exan, and LabNet, among others. Henry Schein One also will include the dental businesses of Internet Brands, including web-based solutions such as Demandforce, Sesame Communications, Officite, and DentalPlans.com. The teams dedicated to all these businesses will become part of the joint venture, which will initially employ approximately 1,500 team members and be headquartered in American Fork, Utah.

Henry Schein will have majority ownership of the joint venture and Internet Brands will own a minority interest, with senior management from Henry Schein and Internet Brands serving on the board of Henry Schein One. The combined entity, which will serve markets globally, had pro-forma 2017 sales of approximately $400 million. Henry Schein expects the transaction to be neutral to the balance of its 2018 earnings per share, excluding the impact of one-time transfer taxes of approximately $4.5 million, or $0.03 per share, related to completing the transaction, and to be accretive thereafter. The joint venture expects to realize between $20 million and $30 million in annual synergies by the end of year three. The companies expect to complete the transaction in the second quarter of 2018, subject to certain pre-closing conditions. Financial terms of the agreement were not disclosed.

"We are very pleased to create this joint venture with Internet Brands because we share the goal of being the best partner to help our dental customers operate successful practices for the ultimate benefit of their patients," said Stanley M. Bergman, Chairman of the Board and CEO, Henry Schein, Inc. "With this agreement, we combine two dental technology leaders who together will create a powerful new engine to accelerate our customers' growth. We believe our customers will have the most extensive suite of integrated programs and services, operating on leading practice management systems, to enable dental professionals to be more efficient and to increase their ability to deliver high-quality care to patients."

Henry Schein One will deliver advanced, cutting-edge technology to address the challenges created by the current lack of technology integration in dental practices. Dental teams today use disparate technology systems that often don't connect with each another, thereby wasting time for the team and their patients. The mission of Henry Schein One is to raise the level of innovation and deliver a new platform of enhanced dental software and services that work together seamlessly to share data and streamline the digital workflow for each member of the dental team. Having end-to-end management and marketing systems will enable dental teams to be better business managers, clinicians to be more efficient, and patients more loyal to the practice. By helping each member of the dental team work smarter and faster to improve the practice and the entire patient experience, Henry Schein One will position dentists to focus more on delivering quality patient care.

Integrating Henry Schein's practice management software with Internet Brands' web-based and mobile digital marketing and communications tools will give dental teams new tools connected to their practice management systems to better communicate with current and prospective patients, minimize appointment cancellations, improve adherence to treatment plans, and develop new sources of revenue.

"By combining Henry Schein's strength in practice management software with our leading digital marketing applications in this new joint venture, we intend to leverage the considerable resources of both companies to provide our customers and their patients with a better experience," said Bob Brisco, CEO of Internet Brands. "We are only scratching the surface of what we can do together to improve how dental practices interact with patients in an age of digital communications. This joint venture will harness the power of the leading brands in this market for the benefit of everyone interested in delivering and experiencing better health care. We're very excited to work with Henry Schein to create a powerful new offering that is unmatched in the industry."

The leadership of Henry Schein One brings deep knowledge and experience to the task of using modern marketing and communications technologies to enhance the customer experience. The company's Chief Executive Officer will be James A. Harding, currently the Senior Vice President and CEO of Henry Schein's Global Practice Solutions Group. Mr. Harding has also served as the Chief Technology Officer of Henry Schein, which he joined in 2000. The remainder of Henry Schein One's management team will be announced at a later date.

Cautionary Note Regarding Forward-Looking Statements and Use of Non-GAAP Financial Information

In accordance with the "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995, we provide the following cautionary remarks regarding important factors that, among others, could cause future results to differ materially from the forward-looking statements, expectations and assumptions expressed or implied herein. These statements are identified by the use of such terms as "may," "could," "expect," "intend," "believe," "plan," "estimate," "forecast," "project," "anticipate" or other comparable terms. Such forward-looking statements include, but are not limited to, statements about the benefits of the joint venture transaction, including future financial and operating results, the joint venture's plans, objectives, expectations and intentions. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future — including statements relating to anticipated synergies and the expected timetable for completing the proposed transaction — are forward-looking statements. All forward-looking statements made by us are subject to risks and uncertainties and are not guarantees of future performance. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance and achievements or industry results to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. For example, these forward-looking statements could be affected by factors including, without limitation, risks associated with the ability to consummate the transaction and the timing of the closing of the transaction; the ability to obtain requisite approvals; the ability to successfully integrate operations and employees; the ability to realize anticipated benefits and synergies of the transaction; the potential impact of the announcement of the transaction or consummation of the transaction on relationships, including with employees, customers and competitors; the ability to retain key personnel; the ability to achieve performance targets; changes in financial markets, interest rates and foreign currency exchange rates; and those additional risks and factors discussed in reports filed with the SEC by Henry Schein from time to time, including those discussed under the heading "Risk Factors" in its most recently filed report on Form 10-K. We undertake no duty and have no obligation to update any forward-looking statements contained herein.

Also included within this press release is guidance regarding the neutral impact of the joint venture transaction on our adjusted earnings per share ("EPS"). This guidance is a non-GAAP financial measure because it excludes the impact of transfer taxes that will be paid in accordance with the joint venture. The reconciliation to the impact of the joint venture on our expected GAAP EPS is provided above. Management believes that this non-GAAP financial measure provides investors with useful supplemental information about the expected impact of the joint venture transaction because it excludes one-time payments that are not indicative of the expected impact of the joint venture on our EPS in future periods. This non-GAAP financial measures is presented solely for informational purposes and should not be regarded as a replacement for corresponding GAAP measures.

About Henry Schein, Inc. 

Henry Schein, Inc. (Nasdaq: HSIC) is a health solutions network powered by people and technology. With more than 22,000 Team Schein Members serving more than 1 million customers globally, the Company is the world's largest provider of Business, Clinical, Technology, and Supply Chain solutions to enhance the efficiency of office-based dental, animal health, and medicalpractitioners. The Company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites.

A Fortune 500® Company and a member of the S&P 500® and the Nasdaq 100® indexes, Henry Schein's network of trusted advisors provides health care professionals with the valued solutions they need to improve operational success and clinical outcomes. The Company offers customers exclusive, innovative products and solutions, including practice management software, e-commerce solutions, specialty and surgical products, as well as a broad range of financial services. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items.

Headquartered in Melville, N.Y., Henry Schein has operations or affiliates in 34 countries. The company's sales reached a record $12.5 billion in 2017, and have grown at a compound annual rate of approximately 15 percent since Henry Schein became a public company in 1995. For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein,and @HenrySchein on Twitter.

About Internet Brands

Headquartered in El Segundo, Calif., Internet Brands® is a fully integrated online media and software services organization focused on four high-value vertical categories: Health, Automotive, Legal and Home/Travel. The company's award-winning consumer websites lead their categories and serve more than 250 million monthly visitors, while a full range of web presence offerings has established deep, long-term relationships with SMB and enterprise clients. Internet Brands' powerful, proprietary operating platform provides the flexibility and scalability to fuel the company's continued growth. Internet Brands is a portfolio company of KKR and Temasek. For more information, please visit www.internetbrands.com. 

The National Institute of Dental & Craniofacial Research, part of the National Institutes of Health, has awarded a grant to researchers at New York University College of Dentistry (NYU Dentistry) to explore the biological mechanisms that contribute to poor oral health and related bone loss among people with diabetes. The grant (R01DE027074), which began April 1, provides $2.2 million over five years.

People with type 2 diabetes are prone to developing periodontitis, or inflammation of the gums and supporting structures of the teeth. The International Diabetes Federation estimates that at least 55 percent of people with diabetes will develop chronic periodontitis.

Periodontitis involves an elevated inflammatory response and greater bone resorption, or the breakdown of bone tissue, by osteoclasts. Diabetes may accelerate periodontitis through metabolic dysregulation, shifts in bacterial colonization, inflammation, and bone loss.

Because bone loss and fracture risk are serious concerns for people with diabetes, Xin Li, PhD, associate professor of basic science and craniofacial biology at NYU College of Dentistry, has been working to understand the underlying mechanism for periodontal bone loss in people with diabetes. In recent studies, including one published last year in Nature Communications, Dr. Li’s research team found that succinate, an important metabolite, is significantly elevated by high blood sugar and in type 2 diabetes patients.

Succinate activates the succinate receptor to stimulate the development of osteoclasts and bone resorption. In a study in mice, periodontal bone loss was greater in normal mice with more succinate and mitigated in mice deficient in the gene for succinate receptors.

“We hypothesize that targeting succinate signaling will prevent the acceleration of periodontal disease. Our research will test this hypothesis and reveal the underlying mechanisms of succinate actions from multiple perspectives,” said Dr. Li, the lead principal investigator of this project.

The new NIDCR grant will fund research to determine whether elevated levels of succinate accelerate the progression of periodontal disease. Using mouse models, the researchers will investigate whether succinate signaling alters the oral microbiome, study the role of succinate as an inflammatory and immune mediator, and determine whether blocking succinate signaling can thwart diabetes-related periodontal bone loss.

“Because we’ve found that succinate has significant implications for periodontal disease, we hope that by understanding this novel mechanism, we can help prevent periodontal bone loss in those with diabetes,” said Deepak Saxena, PhD, associate professor of basic science and craniofacial biology at NYU College of Dentistry and one of the project’s principal investigators.

The project is a collaboration with the University of Pennsylvania School of Dental Medicine (Penn Dental Medicine). Dana T. Graves, DDS, DMSc, interim dean of Penn Dental Medicine, is also a principal investigator.      

Roselle, Ill.—April 2, 2018—PlanmecaUSA hosts “The Digital Age of Orthodontics: Discover the New Digital Workflow Using Planmeca Ultra Low Dose™ in your practice,” on May 4th from 6 p.m. to 9 p.m. at The Hamilton Restaurant, 600 14th Street NW in Washington, D.C.

The seminar is scheduled prior to the start of 2018 AAO Annual Conference and will highlight advanced technologies for orthodontics including: using Planmeca 3D Ultra Low Dose™ protocol, Planmeca Emerald™ Intraoral Digital Scanners, 3D printing, and aligners.

The event features Dr. Jay Burton, from Smile Makers Orthodontics in Nashville, Tenn. 

Dr. Burton will use case studies from his practice to demonstrate how to utilize digital imaging in your practice. He will demonstrate how 3D and digital scanning can guide your treatment planning for optimal outcomes, as well as the use of digital scanners and 3D printing for improved patient care and better return on investment.

To learn more about this technology come see Planmeca at the 2018 AAO Annual Session in May at booth #2233.

To register please use the following link: https://www.planmeca.com/na/aao-patterson.  

Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University’s Brody School of Medicine.

The study, published in The Journal of the American Dental Association, showed an overall decline in dental visits among adults with and without diabetes, but people with diabetes were consistently the least likely to obtain oral healthcare.

Research has shown a two-way relationship between diabetes and oral health. People with diabetes are at an increased risk for periodontal disease, a chronic inflammation of the gums and surrounding tissue and bone, while periodontal disease has an adverse effect on blood glucose control – which can contribute to the progression of diabetes. In fact, periodontal disease has been called the “sixth complication” of diabetes after issues like kidney disease, damage to the retina, and heart disease.

“For people living with diabetes, regular dental check-ups – paired with proactive dental and diabetes self-care – are important for maintaining good oral health. Regular dental visits provide opportunities for prevention, early detection, and treatment of periodontal disease, which can potentially help with blood glucose control and preventing complications from diabetes,” said Bei Wu, PhD, Dean's Professor in Global Health and director of Global Health & Aging Research at NYU Meyers and the study’s senior author.

Older studies have shown that individuals with diabetes had fewer dental visits than those without diabetes. In order to have an updated understanding of dental visits among people with diabetes, this study assessed the trends of annual dental visits from 2004 to 2014 in adults with diabetes, prediabetes, and without diabetes, and assessed racial and ethnic disparities in dental visits.

The researchers used data from the Behavioral Risk Factor Surveillance System, an annual telephone survey of U.S. adults during which respondents are asked whether or not they had a dental visit in the past 12 months and whether they were ever diagnosed with diabetes or prediabetes. The study sample included 2.5 million adults age 21 years and older, including 248,203 people with diabetes, 30,520 with prediabetes, and 2,221,534 without diabetes.

The researchers found that people with diabetes were the least likely to visit the dentist, followed by people with prediabetes. From 2004 to 2014, the proportion of annual dental visits declined from 66.1 percent to 61.4 percent among people with diabetes, 66 percent to 64.9 percent among people with prediabetes, and 71.9 percent to 66.5 percent among people without diabetes.  

“This pattern is concerning, given that timely dental care is essential for good oral health, especially in individuals with diabetes. Those who need dental care the most seem to be the least likely to have it,” said study author Huabin Luo, PhD, of East Carolina University.

Several factors may account for the underutilization of dental services by people with diabetes, according to the researchers. People may not be aware of the impact of diabetes on their oral health and vice versa. In addition, in a previous study, individuals with diabetes more frequently reported the cost of dental care as a reason for avoiding routine visits.

The researchers also observed racial and ethnic disparities in dental care. Black and Hispanic individuals were less likely to visit the dentist than were white people, and these disparities persisted over the decade studied. Males and single people were also less likely to regularly visit the dentist than females and married people.

While the study did not measure whether individuals had dental insurance, the researchers found substantial financial barriers to dental services for people with diabetes based comparing dental visits and income levels. The researchers assert that reducing these barriers and improving access to dental providers is needed, especially among people with diabetes and prediabetes.

“Healthcare providers and public health professionals should promote oral health in diabetes management and encourage people with diabetes to visit a dentist at least annually. Increasing access to dental services is vital to achieving this goal,” said Wu, who is also co-director of the NYU Aging Incubator.

In addition to Wu and Luo, study authors include Ronny A. Bell, Wanda Wright, and Qiang Wu of East Carolina University.

Mydent International has introduced Bite Block Covers to its growing line of DEFEND products.

Clear and latex-free, DEFEND Bite Block Covers provide an economical solution by eliminating the need for disinfection or sterilization. The high quality barrier material is designed for use with pano x-ray machine bite blocks.

DEFEND Bite Block Covers are 1” x 2” and come packaged with 300 per box. The product is now available through most dental dealers.

Mydent International is dedicated to fully maintaining its brand promise: "To provide the healthcare professional with the highest quality infection control products, disposables, preventatives, impression material systems, rotary

instruments and restoratives at affordable prices, supported by superior service and 100% Customer Satisfaction."

DEFEND. Works Better. Lasts Longer. Costs Less. For more information on Mydent International and the DEFEND brand of products, call 800-275-0020, or visit www.defend.com.

For some, rinsing with a mouthwash that contains alcohol, polysorbate or artificial colors and flavors can be undesirable. Tom’s of Maine, the #1 natural mouthwash and #1 natural toothpaste brand, is introducing its first mouthwash featuring 6 benefits in 1.

The new mouthwash fights cavities, strengthens enamel, restores minerals, freshens breath, cleans between teeth and is, of course, alcohol free. New Tom’s of Maine Whole Care® Mouthwash provides clinically proven cavity protection with no artificial colors, sweeteners, preservatives or animal ingredients.

"Developing a mouthwash that offers so many benefits wasn’t easy. It took us many years to get it right,” said Lindsey Seavey, oral care brand manager at Tom's of Maine. “We listened to what people want and have created an effective rinse that provides a naturally clean mouth.”

Pair the new Whole Care Mouthwash with Tom’s of Maine Whole Care Toothpaste for a clean mouth, naturally. Tom’s of Maine Whole Care Toothpaste is a multi-benefit, natural toothpaste offering whitening, cavity protection, fresh breath and more. The Tom’s of Maine Whole Care Toothpaste line includes Peppermint, Spearmint, Wintermint and Cinnamon Clove flavors.

Tom’s of Maine Whole Care Mouthwash is available in Fresh Mint flavor at a suggested retail price of $5.49 for 16 oz.

Tom's of Maine has spent nearly 50 years developing natural oral care products with a commitment to making safe and effective products that harness the best of nature. Since 1970, the company gives 10% of profits back every year to help people and the planet.

You can learn more about Tom's of Maine, its complete natural care portfolio and how the company makes its products by visiting www.TomsofMaine.com and www.Facebook.com/TomsofMaine

Every hour, 24-hours-a-day, 365-days-a-year, someone dies of oral or oropharyngeal cancer (cancers of the mouth and upper throat) in the US. However, when oral cancer is detected and treated early, treatment-related health problems are reduced, and survival rates may increase.

This year an estimated 51,550 new cases of oral and oropharyngeal cancers will be diagnosed in the US. Of those individuals, 40 percent will not survive longer than five years, and many who do survive suffer long-term problems, such as severe facial disfigurement or difficulties with eating and speaking. The death rate associated with oral and oropharyngeal cancers remains particularly high because the cancers routinely are discovered late in their development.

This April, as the nation observes the 19th Annual Oral Cancer Awareness Month, the Academy of General Dentistry, the American Academy of Oral and Maxillofacial Pathology, the American Academy of Oral Medicine, the American Academy of Periodontology, the American Association of Oral and Maxillofacial Surgeons, and the American Dental Hygienists' Association are again joining the non-profit Oral Cancer Foundation in its campaign to raise awareness of oral cancer screenings and the importance of early detection.

Regular oral cancer examinations performed by your oral health professional remain the best method for detecting oral cancer in its early stages.

Be Mindful of Symptoms: Public Urged to "Check Your Mouth"

For the first time, the efforts of the Foundation and the six dental associations cited above will be bolstered by the Oral Cancer Foundation's Check Your Mouth™ individual self-discovery initiative (checkyourmouth.org). Check Your Mouth encourages the public to regularly self-check for signs and symptoms of oral cancer between dental visits, and to see a dental professional if they do not improve or disappear after two-three weeks.

Signs and symptoms of oral cancer caused by tobacco usage and/or excessive alcohol usage may include one or more of the following:

Any sore or ulceration that does not heal within 14 days.

A red, white, or black discoloration of the soft tissues of the mouth.

Any abnormality that bleeds easily when touched.

A lump or hard spot in the tissue, usually border of the tongue.

Tissue raised above that which surrounds it; a growth.

A sore under a denture, which even after adjustment of the denture, that does not heal.

A lump or thickening that develops in the mouth.

A painless, firm, fixated lump felt on the outside of the neck, that has been there for at least two weeks.

All these symptoms have the commonality of being persistent and not resolving.

Signs and symptoms of HPV-caused oropharyngeal cancer persist longer than two-three weeks and may include one or more of the following:

Hoarseness or sore throat that does not resolve.

A painless, firm, fixated lump felt on the outside of the neck, which has been there for at least two weeks.

Constant coughing that does not resolve.

Difficulty swallowing; a sensation that food is getting caught in your throat.

An earache on one side (unilateral) that persists for more than a few days.

All of these symptoms have the commonality of being persistent and not resolving.

Always call a dentist right away if there are any immediate concerns.

Risk Factors

Research has identified a number of factors that may contribute to the development of oral and oropharyngeal cancers. Historically, those at an especially high risk of developing oral cancer have been heavy drinkers and smokers older than age 50, but today the cancer also is occurring more frequently in younger, nonsmoking individuals due to HPV16, the virus most commonly associated with cervical cancer.

The sexually transmitted human papillomavirus (HPV16) is related to the increasing incidence of oropharyngeal cancer (most commonly occurring in the tonsils or the base of the tongue). Approximately 99 percent of people who develop an HPV oral infection will clear the virus on their own. In approximately 1 percent of individuals the immune system will not clear the virus, and it can lay dormant for decades before potentially causing a cancer. This occurs mostly in a non-smoking population composed of men four to one over women.

For those who have never had an oral cancer examination, there is no better time to schedule one than during Oral Cancer Awareness Month in April. When you do, be sure to ask that this examination be made a routine part of all of your future dental check-ups. For a list of local dental professionals who are participating in this year's event by offering free oral cancer screenings, visit the Oral Cancer Foundation's website.

About Oral Cancer Awareness Month

Each April, several of the nation's top dental associations join together with the non-profit Oral Cancer Foundation to raise awareness for oral and oropharyngeal cancers. This is an important reminder to the public that when these cancers are detected and treated early, mortality and treatment-related health problems are reduced. For more information visit the Oral Cancer Foundation website at www.oralcancer.org.

Sponsors include: the Academy of General Dentistry (www.agd.org), the American Academy of Oral and Maxillofacial Pathology (www.aaomp.org), the American Academy of Oral Medicine (aaom.com), the American Academy of Periodontology (www.perio.org), the American Association of Oral and Maxillofacial Surgeons (MyOMS.org) and the American Dental Hygienists' Association (adha.org).